BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Stop Loss Hit||Custom
CLSA Maintains Buy on Sun Pharma
CLSA has maintained its buy call on Sun Pharma with target price of Rs 1,130 per share. CLSA expects business likely to pick up in Q1FY16. It sees potential in Sun Pharma to recover lost sales and it also sees low probability of an import alert for its Halol Plant.